Genomtec EBIT/Varat

Mitä Genomtec tekee? Genomtec SA is a company based in Wrocław, Poland, listed on the Warsaw Stock Exchange under the ticker GMT.WA. It has an ISIN code of PLGNMTC00017 and went public through an IPO on March 17, 2021. The company operates in the field of molecular diagnostics, focusing on the research and development of diagnostic equipment. Genomtec SA is known for developing the Genomtec ID platform, a mobile solution designed for genetic diagnosis at the point of patient care. This platform enables diagnostic procedures to be conducted in settings such as primary care clinics, pharmacies, doctor’s offices, and hospital emergency departments without requiring complex laboratory workflows or specialized personnel. The company's technology aims to streamline the diagnostic process, making it more accessible and efficient in various healthcare environments. Genomtec SA's headquarters are located in Wrocław, within the Lower Silesian Voivodeship. The company's website is https://genomtec.com/, where further information about its products and services can be found. As of the available information, Genomtec SA is active in the development and commercialization of its mobile diagnostic platform, targeting healthcare providers seeking to integrate rapid genetic testing into their practice. The company does not specify its sector or industry in the provided data, but it is clearly engaged in medical technology innovation. Genomtec on yksi Eurpooliin suosituimmista yhtiöistä.